• Login
    View Item 
    •   Home
    • 1 Published Research and Commentary
    • Pharmacy
    • View Item
    •   Home
    • 1 Published Research and Commentary
    • Pharmacy
    • View Item
    Jan 19, 2021
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of MSFTitleAuthorsSubjectsPublisherJournalThis CollectionTitleAuthorsSubjectsPublisherJournal

    Alogliptin: A new dipeptidyl peptidase-4 inhibitor for the management of type 2 diabetes mellitus

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Ndefo et al-2014-Alogliptin-A ...
    Size:
    3.070Mb
    Format:
    PDF
    Download
    Authors
    Ndefo, U A
    Okoli, O
    Erowele, G
    Issue Date
    2014-01-15
    
    Metadata
    Show full item record
    Journal
    American Journal of Health-System Pharmacy
    Abstract
    The pharmacology, pharmacodynamics, pharmacokinetics, safety, efficacy, and place in therapy of alogliptin and its combinations for managing type 2 diabetes mellitus are reviewed.
    Publisher
    American Society of Health System Pharmacists
    URI
    http://hdl.handle.net/10144/322484
    DOI
    10.2146/ajhp130131
    PubMed ID
    24375601
    Language
    en
    ISSN
    1535-2900
    ae974a485f413a2113503eed53cd6c53
    10.2146/ajhp130131
    Scopus Count
    Collections
    Pharmacy

    entitlement

    Related articles

    • Alogliptin: a new dipeptidyl peptidase-4 inhibitor for type 2 diabetes mellitus.
    • Authors: Jarvis CI, Cabrera A, Charron D
    • Issue date: 2013 Nov
    • Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin.
    • Authors: Capuano A, Sportiello L, Maiorino MI, Rossi F, Giugliano D, Esposito K
    • Issue date: 2013
    • An update on the clinical pharmacology of the dipeptidyl peptidase 4 inhibitor alogliptin used for the treatment of type 2 diabetes mellitus.
    • Authors: Chen XW, He ZX, Zhou ZW, Yang T, Zhang X, Yang YX, Duan W, Zhou SF
    • Issue date: 2015 Dec
    • The dipeptidyl peptidase-4 inhibitor alogliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis.
    • Authors: Fujii Y, Abe M, Higuchi T, Mizuno M, Suzuki H, Matsumoto S, Ito M, Maruyama N, Okada K, Soma M
    • Issue date: 2013 Feb
    • Alogliptin: safety, efficacy, and clinical implications.
    • Authors: Marino AB, Cole SW
    • Issue date: 2015 Feb
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.